Milestone Pharmaceuticals (MIST) Invested Capital (2023 - 2026)
Milestone Pharmaceuticals' (MIST) quarterly Invested Capital came in at $50.0 million in Q1 2026, little changed YoY from $50.0 million in Q1 2025, and little changed on a QoQ basis from $50.0 million in Q4 2025.
Milestone Pharmaceuticals (MIST) Invested Capital (2023 - 2026) Analysis & Trends
Milestone Pharmaceuticals (MIST) has 4 years of Invested Capital data on file, last reported at $50.0 million in Q1 2026.
- Quarterly Invested Capital changed 0.0% year-over-year to $50.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $200.0 million (changed 0.0% YoY) and the FY2025 annual result came in at $50.0 million, changed 0.0% from the prior year.
- Invested Capital held at $50.0 million in Q1 2026, from $50.0 million in the prior quarter.
- In the past five years, Invested Capital ranged from a high of $50.0 million in Q1 2023 to a low of $50.0 million in Q1 2023.
- A 4-year average of $50.0 million and a median of $50.0 million in 2023 frame the typical range for Invested Capital.
- The widest YoY moves for Invested Capital: up 0.0% in 2024, down 0.0% in 2024.
- Tracing MIST's Invested Capital over 4 years: stood at $50.0 million in 2023, then changed by 0.0% to $50.0 million in 2024, then changed by 0.0% to $50.0 million in 2025, then changed by 0.0% to $50.0 million in 2026.
- The last three Invested Capital figures came in at $50.0 million (Q1 2026), $50.0 million (Q4 2025), and $50.0 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 37.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 190.90 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 1.45 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 380.00 Mn |
| 10 | Milestone Pharmaceuticals | 43.40 Mn | -128.10 Mn | - | 50.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 50.00 Mn |
| Mar 31, 2026 | 50.00 Mn |
| Dec 31, 2025 | 50.00 Mn |
| Sep 30, 2025 | 50.00 Mn |
| Jun 30, 2025 | 50.00 Mn |
| Mar 31, 2025 | 50.00 Mn |
| Dec 31, 2024 | 50.00 Mn |
| Sep 30, 2024 | 50.00 Mn |
| Jun 30, 2024 | 50.00 Mn |
| Mar 31, 2024 | 50.00 Mn |
| Dec 31, 2023 | 50.00 Mn |
| Sep 30, 2023 | 50.00 Mn |
| Jun 30, 2023 | 50.00 Mn |
| Mar 31, 2023 | 50.00 Mn |